India Pharmaceutical Packaging Market is Anticipated to Witness High Growth Owing to Increased Pharmaceutical Sector Growth

 

India Pharmaceutical Packaging Market

The pharmaceutical packaging market in India has witnessed significant growth over the past few years. Pharmaceutical packaging offers product safety, protection against external factors like contamination from moisture, oxygen, and sunlight. It further facilitates ease of transportation, inventory management, product identification, and brand promotion. The pharmaceutical industry in India has witnessed substantial growth in recent times and has emerged as the third-largest pharmaceutical market globally. Factors such as increasing healthcare awareness, availability of affordable medicines, access to healthcare facilities, and government initiatives contributing to the pharmaceutical sector growth are key aspects fueling the packaging demand.

The Indian pharmaceutical packaging market is estimated to be valued at US$ 1.96 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period of 2024 to 2031.

With increased accessibility and affordability of medicines, coupled with a robust distribution network, India has become one of the leading pharmaceutical markets globally. Factors such as digitalization, strategic initiatives to promote local manufacturing, push towards self-sufficiency during the COVID crisis are further strengthening the pharmaceutical sector in India. This anticipated growth trajectory of the pharmaceutical industry will continue driving packaging demand over the coming years.

Key Takeaways
Key players operating in the India pharmaceutical packaging market are IBM Corporation, Lucid Work Incorporation, Microsoft Corporation, Dassault Systems S.A., Oracle Corporation, X1 Technologies Inc., SAP AG, Coveo Corporation, and Attivio Software Incorporation. These key players are focusing on expanding their product portfolio and market presence through new product launches and mergers & acquisitions.

Various opportunities exist in the India Pharmaceutical Packaging Market Size including growth in chronic disease treatment, development of biopharmaceuticals, growth of medical devices industry. Additionally, increasing focus on patient safety and compliance is further driving innovative packaging solutions.

Growing pharmaceutical exports from India coupled with increased global focus on reducing medical costs through affordable drugs from India provide significant potential for global expansion of Indian pharmaceutical packaging companies. To capitalize on this opportunity, key packaging players are investing in increasing their manufacturing capabilities and distribution networks.

Market drivers: Growing pharmaceutical industry in India: Increase in chronic diseases, health awareness, expenditure on healthcare is contributing significantly to pharmaceutical industry growth thus driving packaging demand.

Market restraints: Stringent regulatory landscape: Frequent regulatory changes regarding packaging material selection, design and labeling requirements particularly for temperature sensitive drugs can hinder packaging innovation.


Segment Analysis
The India pharmaceutical packaging market can be segmented based on packaging type into primary packaging, secondary packaging, and tertiary packaging. Within primary packaging, blister packaging dominates as it provides efficient protection and dispensing of drugs in solid, semi-solid, and liquid forms. Blister packaging prevents contamination and product damage and allows producing drugs in unit doses, thus ensuring product safety and efficacy.

The secondary segment can be divided into label & accessories and container. Label & accessories is the fastest growing secondary segment due to stringent serialization & labelling regulations in the country. The labelling segment is seeing increased innovation to include advanced digital solutions such as 2D barcodes to enable supply chain traceability and prevent counterfeiting.

Global Analysis
Regionally, Southern India dominates the pharmaceutical packaging market backed by the presence of a large number of pharmaceutical companies in cities like Hyderabad, Chennai and Bengaluru. The stringent implementation of the Pharmacopoeia and serialization requirements are also boosting market growth in this region.

Meanwhile, the Western region is the fastest growing region due to rising investments from domestic as well as international pharma players in states like Gujarat and Maharashtra. This has necessitated increased local production and packaging of drugs. Furthermore, these regions are witnessing growing demand for compliance with global packaging standards to facilitate exports.

Explore Our More Blogs on India Pharmaceutical Packaging Market

Comments

Post a Comment

Popular posts from this blog

The global Blast Resistant and Bulletproof Buildings Market Growth Accelerated by Rising Threats

Image
Blast resistant and bulletproof buildings provide protection against explosions, bomb threats and gunfire. They use composite or alloy materials like ballistic glass, reinforced steel and concrete which reinforce structures and withstand blasts or projectiles. The rising threats of terrorist attacks and military aggressions have increased the demand for such secure buildings for government infrastructures, embassies, military installations and other high-security areas. The global Blast Resistant and Bulletproof Buildings Market is estimated to be valued at US$ 1.28 Mn in 2024 and is expected to exhibit a CAGR of 3.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The demand for blast resistant and bulletproof buildings has risen significantly owing to increasing geopolitical conflicts and threats across the world. Majority of countries are allocating higher defense budgets for construction of secure...
Read more

Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market is Anticipated to Witness High Growth Owing to Increasing Business Events

Image
  Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market The Saudi Arabia MICE market refers to meetings, incentives, conferences, and exhibitions which cater to business events in the country. MICE activities help businesses to hold strategy and planning meetings, incentive travel programs, product launches, training seminars, and exhibitions. The events industry helps hotels, airlines, transportation, food & beverage sectors in Saudi Arabia. Growing awareness about MICE and its impact on economy is encouraging businesses to organize more events. The Saudi Vision 2030 aims to diversify economy away from oil and develop tourism and entertainment industries which will further boost the MICE market. The Global Saudi Arabia Meetings, Incentives, Conferences and Exhibitions (MICE) Market is estimated to be valued at US$ 2.69 Bn in 2024 and is expected to exhibit a CAGR of 5.7% over the forecast period 2024 to 2031. Key Takeaways Key players operating in ...
Read more

Mometasone Furoate Market Poised for High Growth Due to Rising Prevalence of Respiratory Diseases

Image
  Mometasone Furoate Market Mometasone furoate is a corticosteroid used for the treatment and prevention of asthma, allergic rhinitis, nasal polyps, skin diseases and other inflammatory conditions. It is typically administered as an inhaled medication for asthma and as a topical cream or ointment for skin conditions like dermatitis and eczema. Mometasone furoate works by reducing inflammation and helps ease symptoms like wheezing, breathlessness, and itching caused by various inflammatory reactions in the body. The growing prevalence of asthma and other allergic diseases globally has significantly boosted the demand for mometasone furoate based drugs and products. The global mometasone furoate market is estimated to be valued at US$ 1467.01 Bn in 2024 and is expected to exhibit a CAGR of 22% over the forecast period 2024 to 2031. Key Takeaways Key players operating in the mometasone furoate market are Thermo Fisher Scientific, Merck KGaA, Danaher Corporation, Lonza Group, Mil...
Read more